Trending
M4 Mac mini hits $769.99 in Amazon Father's Day saleI stopped using idle games for focus and switched to a desktop pet that actually helpsGemini's Daily Brief replaced my morning routine, and I'm shocked how well it worksESWATINI, INDONESIA DEEPEN STRATEGIC TIES ON AGRICULTURE, WELLNESS INDUSTRYHungary scrambles fighter jets after Israeli passenger plane fails to contact ground controlUnhealthy air quality in California city as huge warehouse fire burns for 3rd dayLink aggregation sounded like free internet speed until I learned what it actually doesApple Watch Alternatives That Will Last For 7 Days On A ChargeDJI and Insta360 locked in global patent war over creator camera technologyShould the boost in Aussie house prices bring Kiwi homeowners hope?You think you’re cutting your power bill - but you could end up paying moreWhat To Expect? » MotorOctaneM4 Mac mini hits $769.99 in Amazon Father's Day saleI stopped using idle games for focus and switched to a desktop pet that actually helpsGemini's Daily Brief replaced my morning routine, and I'm shocked how well it worksESWATINI, INDONESIA DEEPEN STRATEGIC TIES ON AGRICULTURE, WELLNESS INDUSTRYHungary scrambles fighter jets after Israeli passenger plane fails to contact ground controlUnhealthy air quality in California city as huge warehouse fire burns for 3rd dayLink aggregation sounded like free internet speed until I learned what it actually doesApple Watch Alternatives That Will Last For 7 Days On A ChargeDJI and Insta360 locked in global patent war over creator camera technologyShould the boost in Aussie house prices bring Kiwi homeowners hope?You think you’re cutting your power bill - but you could end up paying moreWhat To Expect? » MotorOctane

Talquetamab Plus Daratumumab Improves PFS in Relapsed/Refractory Myeloma

In MonumenTAL-3, talquetamab plus daratumumab with or without pomalidomide significantly improved PFS vs DPd in relapsed/refractory myeloma....

News Desk

Staff Writer

Published

Jun 14, 2026

Source

CancerNetwork

Analytics

0 0 0
Talquetamab Plus Daratumumab Improves PFS in Relapsed/Refractory Myeloma

AI Insight:This story is currently being processed. Visit Plainscan for the latest updates.

Our news engine is processing this article. Please visit the source link to read the full story.